Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 6412682, 14 pages
https://doi.org/10.1155/2017/6412682
Research Article

Mitochondria-Targeted Antioxidants SkQ1 and MitoTEMPO Failed to Exert a Long-Term Beneficial Effect in Murine Polymicrobial Sepsis

1Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in the Trauma Research Center of AUVA, Vienna, Austria
2Institute of Surgical Research, Faculty of Medicine, University of Szeged, Szeged, Hungary
3Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany
4A.N. Belozersky Institute of Physico-Chemical Biology, M.V. Lomonosov Moscow State University, Leninskie Gory, Moscow 119992, Russia
5Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany

Correspondence should be addressed to Marcin F. Osuchowski; ta.ca.gbl.amuart@ikswohcuso.nicram

Received 30 March 2017; Revised 22 June 2017; Accepted 2 August 2017; Published 19 September 2017

Academic Editor: Moh H. Malek

Copyright © 2017 Pia Rademann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Singer, C. S. Deutschman, C. W. Seymour et al., “The third international consensus definitions for sepsis and septic shock (sepsis-3),” The Journal of the American Medical Association, vol. 315, no. 8, pp. 801–810, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. K. N. Iskander, M. F. Osuchowski, D. J. Stearns-Kurosawa et al., “Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding,” Physiological Reviews, vol. 93, pp. 1247–1288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rocha, R. Herance, S. Rovira, A. Hernández-Mijares, and V. M. Victor, “Mitochondrial dysfunction and antioxidant therapy in sepsis,” Infectious Disorders Drug Targets, vol. 12, pp. 161–178, 2012. View at Publisher · View at Google Scholar
  4. A. Phaniendra, D. B. Jestadi, and L. Periyasamy, “Free radicals: properties, sources, targets, and their implication in various diseases,” Indian Journal of Clinical Biochemistry, vol. 30, pp. 11–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” The Journal of Physiology, vol. 552, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. P. Murphy, “How mitochondria produce reactive oxygen species,” The Biochemical Journal, vol. 417, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” The International Journal of Biochemistry & Cell Biology, vol. 39, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Nordberg and E. S. Arnér, “Reactive oxygen species, antioxidants, and the mammalian thioredoxin system,” Free Radical Biology and Medicine, vol. 31, pp. 1287–1312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. P. Soares, R. Gozzelino, and S. Weis, “Tissue damage control in disease tolerance,” Trends in Immunology, vol. 35, pp. 483–494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. I. B. Slimen, T. Najar, A. Ghram, H. Dabbebi, M. Ben Mrad, and M. Abdrabbah, “Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review,” International Journal of Hyperthermia, vol. 30, pp. 513–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. E. R. Stadtman and R. L. Levine, “Protein oxidation,” Annals of the New York Academy of Sciences, vol. 899, pp. 191–208, 2000. View at Publisher · View at Google Scholar
  12. E. D. Crouser, “Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome,” Mitochondrion, vol. 4, pp. 729–741, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Y. Plotnikov, M. A. Morosanova, I. B. Pevzner et al., “Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, pp. E3100–E3108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. I. Galkin, O. Y. Pletjushkina, R. A. Zinovkin et al., “Mitochondria-targeted antioxidants prevent TNFα-induced endothelial cell damage,” Biochemistry (Moscow), vol. 79, pp. 124–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. A. Lowes, N. R. Webster, M. P. Murphy, and H. F. Galley, “Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress , improve mitochondrial function , and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis,” British Journal of Anaesthesia, vol. 110, pp. 472–480, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Lowes, B. M. V. Thottakam, N. R. Webster, M. P. Murphy, and H. F. Galley, “The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis,” Free Radical Biology & Medicine, vol. 45, pp. 1559–1565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Sener, H. Toklu, C. Kapucu et al., “Melatonin protects against oxidative organ injury in a rat model of sepsis,” Surgery Today, vol. 35, pp. 52–59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Macarthur, D. M. Couri, G. H. Wilken et al., “Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines,” Critical Care Medicine, vol. 31, pp. 237–245, 2003. View at Google Scholar
  19. G. S. Supinski, M. P. Murphy, and L. A. Callahan, “MitoQ administration prevents endotoxin-induced cardiac dysfunction,” American Journal of Physiology Regulatory, Integrative and Comparative Physiology, vol. 297, pp. R1095–R1102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Heyland, J. Muscedere, P. E. Wischmeyer et al., “A randomized trial of glutamine and antioxidants in critically ill patients,” The New England Journal of Medicine, vol. 368, pp. 1489–1497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. B. J. Snow, F. L. Rolfe, M. M. Lockhart et al., “A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson’s disease,” Movement Disorders, vol. 25, pp. 1670–1674, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Kaufmann, J. L. P. Thompson, G. Levy et al., “Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III,” Annals of Neurology, vol. 66, pp. 235–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Osuchowski, D. G. Remick, J. A. Lederer et al., “Abandon the mouse research ship? Not just yet!,” Shock, vol. 41, pp. 463–475, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Phillip Dellinger and J. E. Parrillo, “Mediator modulation therapy of severe sepsis and septic shock: does it work?” Critical Care Medicine, vol. 32, pp. 282–286, 2004. View at Publisher · View at Google Scholar
  25. W. Stahl, M. Matejovic, and P. Radermacher, “Inhibition of nitric oxide synthase during sepsis: revival because of isoform selectivity?” Shock, vol. 34, pp. 321-322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. P. Murphy and R. A. J. Smith, “Targeting antioxidants to mitochondria by conjugation to lipophilic cations,” Annual Review of Pharmacology and Toxicology, vol. 47, pp. 629–656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Ross, G. F. Kelso, F. H. Blaikie et al., “Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology,” Biochemistry (Moscow), vol. 70, pp. 222–230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. F. Galley, “Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis,” Critical Care, vol. 14, p. 230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. V. P. Skulachev, “A biochemical approach to the problem of aging: “megaproject” on membrane-penetrating ions. The first results and prospects,” Biochemistry (Moscow), vol. 72, pp. 1385–1396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. N. Antonenko, A. V. Avetisyan, L. E. Bakeeva et al., “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies,” Biochemistry (Moscow), vol. 73, pp. 1273–1287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. V. N. Manskikh, O. S. Gancharova, A. I. Nikiforova et al., “Age-associated murine cardiac lesions are attenuated by the mitochondria-targeted antioxidant SkQ1,” Histology and Histopathology, vol. 30, pp. 353–360, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. V. N. Anisimov, M. V. Egorov, M. S. Krasilshchikova et al., “Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents,” Aging (Albany, New York), vol. 3, pp. 1110–1119, 2011. View at Publisher · View at Google Scholar
  33. A. E. Dikalova, A. T. Bikineyeva, K. Budzyn et al., “Therapeutic targeting of mitochondrial superoxide in hypertension,” Circulation Research, vol. 107, pp. 106–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Wang, F. Cai, X. Chen, M. Luo, L. Hu, and Y. Lu, “The role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosis,” PLoS One, vol. 8, article e75044, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. K. Patil, N. Parajuli, L. A. MacMillan-Crow, and P. R. Mayeux, “Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury,” American Journal of Physiology Renal Physiology, vol. 306, pp. F734–F743, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Yang, S. Karakhanova, S. Soltek, J. Werner, P. P. Philippov, and A. V. Bazhin, “In vivo immunoregulatory properties of the novel mitochondria-targeted antioxidant SkQ1,” Molecular Immunology, vol. 52, pp. 19–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Ma, S. Chen, Q. Hu, H. Feng, J. H. Zhang, and J. Tang, “NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage,” Annals of Neurology, vol. 75, pp. 209–219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Nemzek, K. M. S. Hugunin, and M. R. Opp, “Modeling sepsis in the laboratory: merging sound science with animal well-being,” Comparative Medicine, vol. 58, pp. 120–128, 2008, http://www.Ncbi.Nlm.Nih.Gov/pubmed/18524169. View at Google Scholar
  39. J. A. Nemzek, H.-Y. Xiao, A. E. Minard, G. L. Bolgos, and D. G. Remick, “Humane endpoints in shock research,” Shock, vol. 21, pp. 17–25, 2004. View at Publisher · View at Google Scholar
  40. E. Lilley, R. Armstrong, N. Clark et al., “Refinement of animal models of sepsis and septic shock,” Shock, vol. 43, pp. 304–316, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Drechsler, K. M. Weixelbaumer, A. Weidinger et al., “Why do they die? Comparison of selected aspects of organ injury and dysfunction in mice surviving and dying in acute abdominal sepsis,” Intensive Care Medicine Experimental, vol. 3, p. 48, 2015. View at Publisher · View at Google Scholar
  42. K. A. Wichterman, A. E. Baue, and I. H. Chaudry, “Sepsis and septic shock--a review of laboratory models and a proposal,” The Journal of Surgical Research, vol. 29, pp. 189–201, 1980. View at Publisher · View at Google Scholar
  43. P. Raeven, G. A. Feichtinger, K. M. Weixelbaumer et al., “Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcome of murine polymicrobial sepsis,” Thrombosis Research, vol. 129, pp. e238–e245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. T. M. Osborn, J. K. Tracy, J. R. Dunne, M. Pasquale, and L. M. Napolitano, “Epidemiology of sepsis in patients with traumatic injury,” Critical Care Medicine, vol. 32, pp. 2234–2240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. J.-L. Vincent, Y. Sakr, C. L. Sprung et al., “Sepsis in European intensive care units: results of the SOAP study,” Critical Care Medicine, vol. 34, pp. 344–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. K. N. Iskander, M. Vaickus, E. R. Duffy, and D. G. Remick, “Shorter duration of post-operative antibiotics for cecal ligation and puncture does not increase inflammation or mortality,” PLoS One, vol. 11, article e0163005, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Piskernik, S. Haindl, T. Behling et al., “Antimycin A and lipopolysaccharide cause the leakage of superoxide radicals from rat liver mitochondria,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1782, pp. 280–285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. F. Osuchowski, K. Welch, J. Siddiqui, and D. G. Remick, “Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality,” Journal of Immunology, vol. 177, pp. 1967–1974, 2006. View at Publisher · View at Google Scholar
  49. M. F. Osuchowski, J. Connett, K. Welch, J. Granger, and D. G. Remick, “Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis,” Critical Care Medicine, vol. 37, pp. 1567–1573, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Weidinger, A. Müllebner, J. Paier-Pourani et al., “Vicious inducible nitric oxide synthase-mitochondrial reactive oxygen species cycle accelerates inflammatory response and causes liver injury in rats,” Antioxidants & Redox Signaling, vol. 22, pp. 572–586, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. K. M. Weixelbaumer, P. Raeven, H. Redl, M. v. Griensven, S. Bahrami, and M. F. Osuchowski, “Repetitive low-volume blood sampling method as a feasible monitoring tool in a mouse model of sepsis,” Shock, vol. 34, pp. 420–426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Ray and B. N. Dittel, “Isolation of mouse peritoneal cavity cells,” Journal of Visualized Experiments, vol. 35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Barquero-Calvo, C. Chacon-Diaz, E. Chaves-Olarte, and E. Moreno, “Bacterial counts in spleen,” BIO-PROTOCOL, vol. 3, 2013. View at Publisher · View at Google Scholar
  54. H. Chaudhry, J. Zhou, Y. Zhong et al., “Role of cytokines as a double-edged sword in sepsis,” In Vivo, vol. 27, pp. 669–684, 2013, http://www.Ncbi.Nlm.Nih.Gov/pubmed/24292568. View at Google Scholar
  55. J.-M. Cavaillon, M. Adib-Conquy, C. Fitting, C. Adrie, and D. Payen, “Cytokine cascade in sepsis,” Scandinavian Journal of Infectious Diseases, vol. 35, pp. 535–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Wang, C. Wang, F. Yan et al., “N-Acetylcysteine attenuates diabetic myocardial ischemia reperfusion injury through inhibiting excessive autophagy,” Mediators of Inflammation, vol. 2017, Article ID 9257291, 10 pages, 2017. View at Publisher · View at Google Scholar
  57. H. F. Galley, “Oxidative stress and mitochondrial dysfunction in sepsis,” British Journal of Anaesthesia, vol. 107, pp. 57–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Mazumder, R. De, S. Sarkar et al., “Selective scavenging of intra-mitochondrial superoxide corrects diclofenac-induced mitochondrial dysfunction and gastric injury: a novel gastroprotective mechanism independent of gastric acid suppression,” Biochemical Pharmacology, vol. 121, pp. 33–51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. V. V. Zakharova, O. Y. Pletjushkina, I. I. Galkin et al., “Low concentration of uncouplers of oxidative phosphorylation decreases the TNF-induced endothelial permeability and lethality in mice,” Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1863, pp. 968–977, 2017. View at Publisher · View at Google Scholar
  60. Q. S. Zang, H. Sadek, D. L. Maass et al., “Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model,” American Journal of Physiology Heart and Circulatory Physiology, vol. 302, pp. H1847–H1859, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. W. Huang, N. Cash, L. Wen et al., “Effects of the mitochondria-targeted antioxidant mitoquinone in murine acute pancreatitis,” Mediators of Inflammation, vol. 2015, Article ID 901780, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. A. V. Bazhin, Y. Yang, J. G. D’Haese, J. Werner, P. P. Philippov, and S. Karakhanova, “The novel mitochondria-targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthotopic model of pancreatic cancer,” International Journal of Cancer, vol. 139, pp. 130–139, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Abitagaoglu, S. B. Akinci, F. Saricaoglu et al., “Effect of coenzyme Q10 on organ damage in sepsis,” Bratislava Medical Journal, vol. 116, pp. 433–439, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Drechsler, K. M. Weixelbaumer, H. Redl, M. van Griensven, S. Bahrami, and M. F. Osuchowski, “Experimentally approaching the ICU: monitoring outcome-based responses in the two-hit mouse model of posttraumatic sepsis,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 357926, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. M. F. Osuchowski, F. L. Craciun, E. Schuller, C. Sima, R. Gyurko, and D. G. Remick, “Untreated type 1 diabetes increases sepsis-induced mortality without inducing a prelethal cytokine response,” Shock, vol. 34, pp. 369–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. M.-H. Liao, S.-J. Chen, C.-M. Tsao, C.-C. Shih, and C.-C. Wu, “Possible biomarkers of early mortality in peritonitis-induced sepsis rats,” The Journal of Surgical Research, vol. 183, pp. 362–370, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. Y.-J. Zhang, M. Li, M. Meng, M. Feng, and C.-Y. Qin, “The effect of ulinastatin on the small intestine injury and mast cell degranulation in a rat model of sepsis induced by CLP,” Experimental and Toxicologic Pathology, vol. 61, pp. 481–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. A. V. Kozlov, J. R. Lancaster, A. T. Meszaros, and A. Weidinger, “Mitochondria-meditated pathways of organ failure upon inflammation,” Redox Biology, vol. 13, pp. 170–181, 2017. View at Publisher · View at Google Scholar
  69. A. C. Bulua, A. Simon, R. Maddipati et al., “Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS),” The Journal of Experimental Medicine, vol. 208, pp. 519–533, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Zhou, A. S. Yazdi, P. Menu, and J. Tschopp, “A role for mitochondria in NLRP3 inflammasome activation,” Nature, vol. 469, pp. 221–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Naik and V. M. Dixit, “Mitochondrial reactive oxygen species drive proinflammatory cytokine production,” The Journal of Experimental Medicine, vol. 208, pp. 417–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Weidinger and A. V. Kozlov, “Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction,” Biomolecules, vol. 5, pp. 472–484, 2015. View at Publisher · View at Google Scholar
  73. T. Klimova and N. S. Chandel, “Mitochondrial complex III regulates hypoxic activation of HIF,” Cell Death and Differentiation, vol. 15, pp. 660–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. D. R. Janz and L. B. Ware, “The role of red blood cells and cell-free hemoglobin in the pathogenesis of ARDS,” Journal of Intensive Care, vol. 3, p. 20, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. D. R. Janz, J. A. Bastarache, T. W. Rice et al., “Acetaminophen for the reduction of oxidative injury in severe sepsis study group, randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the acetaminophen for the reduction of oxidative injury in severe sepsis trial,” Critical Care Medicine, vol. 43, pp. 534–541, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Weis, A. R. Carlos, M. R. Moita et al., “Metabolic adaptation establishes disease tolerance to sepsis,” Cell, vol. 169, article e14, pp. 1263–1275, 2017. View at Publisher · View at Google Scholar
  77. C. F. Benjamim, C. Canetti, F. Q. Cunha, S. L. Kunkel, and M. Peters-Golden, “Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis,” Journal of Immunology, vol. 174, pp. 1616–1620, 2005. View at Publisher · View at Google Scholar
  78. F. Rios-Santos, C. F. Benjamim, D. Zavery, S. H. Ferreira, and F. de Queiroz Cunha, “A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligation and puncture sepsis,” Shock, vol. 19, pp. 61–65, 2003. View at Publisher · View at Google Scholar
  79. P. Raeven, S. Drechsler, K. M. Weixelbaumer et al., “Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP mice,” Journal of Thrombosis and Haemostasis, vol. 12, pp. 958–969, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Bylund, M. Samuelsson, L. V. Collins, and A. Karlsson, “NADPH-oxidase activation in murine neutrophils via formyl peptide receptors,” Experimental Cell Research, vol. 282, pp. 70–77, 2003. View at Publisher · View at Google Scholar · View at Scopus